Fresenius Medical Care AG KGaA Total Long-Term Assets 2010-2024 | FMS

Fresenius Medical Care AG KGaA total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
  • Fresenius Medical Care AG KGaA total long-term assets for the quarter ending December 31, 2024 were $27.749B, a 1.63% increase year-over-year.
  • Fresenius Medical Care AG KGaA total long-term assets for 2024 were $27.749B, a 1.63% increase from 2023.
  • Fresenius Medical Care AG KGaA total long-term assets for 2023 were $27.305B, a 5.93% decline from 2022.
  • Fresenius Medical Care AG KGaA total long-term assets for 2022 were $29.027B, a 7.06% decline from 2021.
Fresenius Medical Care AG KGaA Annual Total Long-Term Assets
(Millions of US $)
2024 $27,749
2023 $27,305
2022 $29,027
2021 $31,233
2020 $27,888
2019 $28,862
2018 $21,725
2017 $19,951
2016 $19,620
2015 $18,597
2014 $18,663
2013 $16,833
2012 $16,199
2011 $13,838
2010 $11,942
2009 $11,093
Fresenius Medical Care AG KGaA Quarterly Total Long-Term Assets
(Millions of US $)
2024-12-31 $27,749
2024-09-30 $26,852
2024-06-30 $27,145
2024-03-31 $27,201
2023-12-31 $27,305
2023-09-30 $28,930
2023-06-30 $29,019
2023-03-31 $28,916
2022-12-31 $29,027
2022-09-30 $30,109
2022-06-30 $29,760
2022-03-31 $29,946
2021-12-31 $31,233
2021-09-30 $30,461
2021-06-30 $30,330
2021-03-31 $30,585
2020-12-31 $27,888
2020-09-30 $29,488
2020-06-30 $28,638
2020-03-31 $28,922
2019-12-31 $28,862
2019-09-30 $28,843
2019-06-30 $27,863
2019-03-31 $28,227
2018-12-31 $21,725
2018-09-30 $20,991
2018-06-30 $20,910
2018-03-31 $21,282
2017-12-31 $19,951
2017-09-30 $20,704
2017-06-30 $19,742
2017-03-31 $19,932
2016-12-31 $19,620
2016-09-30 $19,440
2016-06-30 $19,276
2016-03-31 $18,920
2015-12-31 $18,597
2015-09-30 $18,655
2015-06-30 $18,708
2015-03-31 $18,507
2014-12-31 $18,663
2014-09-30 $14,541
2014-06-30 $14,040
2014-03-31 $13,791
2013-12-31 $13,741
2013-09-30 $13,482
2013-06-30 $13,243
2013-03-31 $13,231
2012-12-31 $13,258
2012-09-30 $13,044
2012-06-30 $12,882
2012-03-31 $13,051
2011-12-31 $11,208
2011-09-30 $10,451
2011-06-30 $10,574
2011-03-31 $12,399
2010-12-31 $9,415
2010-09-30 $8,890
2010-06-30 $8,715
2010-03-31 $8,703
2009-12-31 $8,674
2009-09-30 $8,590
2009-06-30 $8,530
2009-03-31 $8,434
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $13.878B $20.627B
Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products..
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $171.942B 78.88
Thermo Fisher Scientific (TMO) United States $161.378B 19.56
Alcon (ALC) Switzerland $45.645B 30.34
Edwards Lifesciences (EW) United States $42.050B 27.30
IDEXX Laboratories (IDXX) United States $33.347B 38.56
DexCom (DXCM) United States $26.887B 41.56
IQVIA Holdings (IQV) United States $25.374B 14.04
STERIS (STE) Ireland $21.834B 24.97
Mettler-Toledo (MTD) United States $20.944B 24.42
Waters (WAT) United States $19.099B 27.04
SONOVA HOLDING (SONVY) Switzerland $17.304B 0.00
Hologic (HOLX) United States $12.916B 13.94
Sysmex ADR (SSMXY) Japan $11.847B 0.00
Penumbra (PEN) United States $10.729B 96.64
Globus Medical (GMED) United States $9.767B 22.61
Masimo (MASI) United States $8.221B 34.50
Teleflex (TFX) United States $6.004B 9.24
Glaukos (GKOS) United States $5.153B 0.00
Integer Holdings (ITGR) United States $4.081B 22.07
TransMedics (TMDX) United States $2.985B 87.37
PROCEPT BioRobotics (PRCT) United States $2.907B 0.00
Veracyte (VCYT) United States $2.427B 43.86
Nihon Kohden (NHNKY) Japan $2.081B 11.37
LivaNova (LIVN) United Kingdom $1.934B 11.74
Elekta AB (EKTAY) Sweden $1.891B 17.00
Alphatec Holdings (ATEC) United States $1.522B 0.00
Integra LifeSciences Holdings (IART) United States $1.222B 6.18
Pulse Biosciences (PLSE) United States $1.193B 0.00
Tandem Diabetes Care (TNDM) United States $1.122B 0.00
Paragon 28 (FNA) United States $1.099B 0.00
Artivion (AORT) United States $0.979B 91.72
OPKO Health (OPK) United States $0.954B 0.00
AxoGen (AXGN) United States $0.690B 0.00
IRadimed (IRMD) United States $0.658B 34.51
Mesa Laboratories (MLAB) United States $0.609B 13.30
SiBone (SIBN) United States $0.588B 0.00
RxSight (RXST) United States $0.584B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.572B 9.21
OrthoPediatrics (KIDS) United States $0.510B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.508B 0.00
Beta Bionics (BBNX) United States $0.483B 0.00
Treace Medical Concepts (TMCI) United States $0.406B 0.00
Delcath Systems (DCTH) United States $0.389B 0.00
AngioDynamics (ANGO) United States $0.387B 0.00
NeuroPace (NPCE) United States $0.351B 0.00
Pacific Biosciences Of California (PACB) United States $0.348B 0.00
ClearPoint Neuro (CLPT) United States $0.342B 0.00
Tactile Systems Technology (TCMD) United States $0.315B 16.87
Semler Scientific (SMLR) United States $0.312B 6.62
Neuronetics (STIM) United States $0.247B 0.00
Inogen (INGN) United States $0.183B 0.00
Alpha Tau Medical (DRTS) Israel $0.181B 0.00
908 Devices (MASS) United States $0.168B 0.00
Spectral Diagnostics (EDTXF) Canada $0.165B 0.00
LENSAR (LNSR) United States $0.164B 0.00
CVRx (CVRX) United States $0.163B 0.00
Accuray (ARAY) United States $0.152B 0.00
Sight Sciences (SGHT) United States $0.137B 0.00
Lucid Diagnostics (LUCD) United States $0.110B 0.00
KORU Medical Systems (KRMD) United States $0.104B 0.00
Rapid Micro Biosystems (RPID) United States $0.104B 0.00
Anteris Technologies Global (AVR) Australia $0.104B 0.00
Monogram Orthopaedics (MGRM) United States $0.095B 0.00
Microbot Medical (MBOT) United States $0.087B 0.00
Atossa Genetics (ATOS) United States $0.080B 0.00
InspireMD (NSPR) Israel $0.079B 0.00
Sensus Healthcare (SRTS) United States $0.076B 11.48
Hyperfine (HYPR) United States $0.054B 0.00
Positron (POSC) United States $0.051B 0.00
EDAP TMS S.A (EDAP) France $0.051B 0.00
EnVVeno Medical (NVNO) United States $0.043B 0.00
Baird Medical Investment Holdings (BDMD) $0.037B 0.00
Vicarious Surgical (RBOT) United States $0.032B 0.00
Spectral AI (MDAI) United States $0.031B 0.00
DarioHealth (DRIO) United States $0.031B 0.00
Precision Optics (POCI) United States $0.030B 0.00
Envoy Medical (COCH) United States $0.029B 0.00
Adagio Medical Holdings (ADGM) United States $0.027B 0.00
NexGel (NXGL) United States $0.022B 0.00
Accelerate Diagnostics (AXDX) United States $0.014B 0.00
PAVmed (PAVM) United States $0.012B 0.00
Ekso Bionics Holdings (EKSO) United States $0.012B 0.00
Biosig Technologies (BSGM) United States $0.010B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.007B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
WORK Medical Technology Group (WOK) China $0.006B 0.00
Nanovibronix (NAOV) United States $0.005B 0.00
Autonomix Medical (AMIX) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00